2017
DOI: 10.1053/j.gastro.2017.05.050
|View full text |Cite
|
Sign up to set email alerts
|

A Summary of the 2016 James W. Freston Conference of the American Gastroenterological Association: Intestinal Metaplasia in the Esophagus and Stomach: Origins, Differences, Similarities and Significance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 19 publications
(14 citation statements)
references
References 87 publications
0
14
0
Order By: Relevance
“…In regions where basal cells showed more uniform metaplasia ("established SPEM"), pS6 levels were lower. In addition, SPEM is thought to progress to (or predate) another, proliferative, pre-cancerous lesion, intestinal metaplasia (Yoshizawa et al, 2007;Correa & Piazuelo, 2012;Spechler et al, 2017) and to increase risk for progression to a cytologically atypical lesion, dysplasia, as well as to cancer itself. In the chronic case, SPEM is equivalent to the lesion pathologists call chronic atrophic gastritis (Rugge et al, 2008).…”
Section: Changes In Mtorc1 Also Characterize Human Metaplasiamentioning
confidence: 99%
See 1 more Smart Citation
“…In regions where basal cells showed more uniform metaplasia ("established SPEM"), pS6 levels were lower. In addition, SPEM is thought to progress to (or predate) another, proliferative, pre-cancerous lesion, intestinal metaplasia (Yoshizawa et al, 2007;Correa & Piazuelo, 2012;Spechler et al, 2017) and to increase risk for progression to a cytologically atypical lesion, dysplasia, as well as to cancer itself. In the chronic case, SPEM is equivalent to the lesion pathologists call chronic atrophic gastritis (Rugge et al, 2008).…”
Section: Changes In Mtorc1 Also Characterize Human Metaplasiamentioning
confidence: 99%
“…In the chronic case, SPEM is equivalent to the lesion pathologists call chronic atrophic gastritis (Rugge et al, 2008). In addition, SPEM is thought to progress to (or predate) another, proliferative, pre-cancerous lesion, intestinal metaplasia (Yoshizawa et al, 2007;Correa & Piazuelo, 2012;Spechler et al, 2017) and to increase risk for progression to a cytologically atypical lesion, dysplasia, as well as to cancer itself.…”
Section: Changes In Mtorc1 Also Characterize Human Metaplasiamentioning
confidence: 99%
“…Therefore, the cell of origin for the metaplastic cells becomes ambiguous and sometimes controversial. Barrett oesophagus has garnered attention in this context 5760 . Studies in transgenic mice have revealed that the interleukin-1β (IL-1β)–IL-6 signalling cascade and Delta-like protein 1 (DLL1)-dependent Notch signalling cause Barrett oesophagus 61 .…”
Section: Cell Of Originmentioning
confidence: 99%
“…In summary, considerable debate continues on the cell of origin of Barrett's oesophagus, 82,83 though it is widely accepted that it is the requisite precursor lesion for the development of OAC. At least four candidate founder cells present themselves: basal cells of the squamous epithelium, stem cells of submucosal ducts, stem cells of the proximal stomach and transitional cells at the SCJ.…”
Section: Alisonmentioning
confidence: 99%